Comparing tTIS treatment intervals to standard care for Parkinson's
Part of Brain & nervous system clinical trials.
This study compares different schedules of a non-invasive brain stimulation treatment (called tTIS) to standard medication for Parkinson's disease. It aims to find the best timing for tTIS to improve motor symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 50 and 85 years old.
- You must have a confirmed diagnosis of Parkinson's disease for at least 6 months.
- Your Parkinson's symptoms should be stable, with no major changes in the last month.
- You must be on stable Parkinson's medication and willing to continue it during the study.
- You must have normal cognitive function (no significant memory or thinking problems).
- You must not have certain conditions like epilepsy, a pacemaker, or metal implants in your head or spine.
- You must not have had deep brain stimulation (DBS) surgery before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a non-invasive brain stimulation technique (using electrical currents applied through the scalp) aimed at the subthalamic nucleus—a brain region involved in movement control—to help reduce both movement-related symptoms (like tremor and stiffness) and non-movement symptoms (like mood and sleep problems) in people with Parkinson's disease.
This study tests a gentle device that stimulates a nerve in the face to see if it helps with movement symptoms in Parkinson's disease. It looks at how this affects walking and balance.
This trial tests a non-invasive brain stimulation technique called transcranial temporal interference stimulation (TTIS) that you can use at home with remote supervision. It aims to improve movement problems like stiffness, tremor, and slowness in people with mild-to-moderate Parkinson's disease.
This study compares two areas of the brain (subthalamic nucleus and globus pallidus interna) for stimulation using a new non-invasive technique called tTIS. The goal is to see which area works better to improve Parkinson's symptoms.
This study tests if a non-invasive brain stimulation technique called rTMS (repetitive Transcranial Magnetic Stimulation) can slow down Parkinson's disease by improving slow-wave sleep. It aims to help people with mild to moderate Parkinson's who are stable on their medication.
This trial tests a new non-invasive brain stimulation method called temporal interference to see if it can improve symptoms of Parkinson's disease. It is for people aged 40 to 80 who are on stable Parkinson's medications and have mild to moderate symptoms.
Hear when a new Parkinson's Disease (PD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.